Ken Research Logo

Saudi Arabia home infusion therapy market size, share, growth drivers, trends, opportunities & forecast 2025–2030

The Saudi Arabia home infusion therapy market, valued at USD 401 million, is growing due to rising chronic diseases, geriatric population, and government initiatives under Vision 2030.

Region:Middle East

Author(s):Rebecca

Product Code:KRAC8407

Pages:95

Published On:November 2025

About the Report

Base Year 2024

Saudi Arabia Home Infusion Therapy Market Overview

  • The Saudi Arabia Home Infusion Therapy Market is valued at USD 401 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and infections, the rising geriatric population, and the growing preference for home healthcare services. The market is further supported by advancements in infusion technology, greater insurance coverage for home-based therapies, and robust government initiatives under Vision 2030 to expand home healthcare infrastructure and services. Investments in healthcare projects and the adoption of portable infusion devices are also accelerating market expansion.
  • Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure, high population density, and the presence of major healthcare facilities. These cities are focal points for healthcare innovation and investment, attracting home infusion therapy services and products and benefiting from government-backed expansion of home healthcare models.
  • In 2023, the Saudi government implemented a regulation requiring all home infusion therapy providers to comply with theSaudi Food and Drug Authority (SFDA) Guidelines for Medical Devices, 2023, issued by the Saudi Food and Drug Authority. This regulation mandates operational standards for device safety, provider licensing, and patient monitoring, ensuring the safety and efficacy of infusion therapies administered at home and enhancing patient care.
Saudi Arabia Home Infusion Therapy Market Size

Saudi Arabia Home Infusion Therapy Market Segmentation

By Product Type:The product type segmentation includes devices and consumables essential for home infusion therapy: Infusion Pumps, Intravenous (IV) Sets, IV Cannulas, Needleless Connectors, and Others. Infusion Pumps are increasingly preferred due to their precision, portability, and ease of use, while IV Sets and Cannulas remain fundamental for therapy administration. The market is experiencing a shift toward advanced, user-friendly devices, including smart infusion pumps and needleless connectors, which are improving safety and patient outcomes.

Saudi Arabia Home Infusion Therapy Market segmentation by Product Type.

By Therapy/Application:This segmentation covers therapeutic applications including Anti-infective Infusion, Parenteral Nutrition, Chemotherapy, Hydration Therapy, Pain Management, and Others. Anti-infective Infusion leads demand due to high infection rates and the need for effective home-based treatment. Parenteral Nutrition and Chemotherapy are also significant, driven by the rising incidence of chronic illnesses and cancer. The market is further shaped by the adoption of home-based hydration and pain management therapies, reflecting a broader shift toward patient-centric, cost-effective care.

Saudi Arabia Home Infusion Therapy Market segmentation by Therapy/Application.

Saudi Arabia Home Infusion Therapy Market Competitive Landscape

The Saudi Arabia Home Infusion Therapy Market is characterized by a dynamic mix of regional and international players. Leading participants such as Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, Smiths Medical, Medtronic plc, ICU Medical, Inc., Halyard Health, Inc., Calea Ltd., Zyno Medical LLC, Amgen Inc., Pfizer Inc., Novartis AG, Roche Holding AG, Sanofi S.A., Al Faisaliah Medical Systems Co. (FMS), Gulf Medical Co. Ltd., Al-Jeel Medical & Trading Co., Tabuk Pharmaceuticals Manufacturing Co., Jamjoom Pharma contribute to innovation, geographic expansion, and service delivery in this space.

Baxter International Inc.

1931

Deerfield, Illinois, USA

B. Braun Melsungen AG

1839

Melsungen, Germany

Fresenius Kabi AG

1999

Bad Homburg, Germany

Terumo Corporation

1921

Tokyo, Japan

Smiths Medical

1980

Minneapolis, Minnesota, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue (Saudi Arabia Home Infusion Therapy, USD Million)

Revenue Growth Rate (YoY %)

Market Share (%)

Number of Patients Served (Saudi Arabia)

Geographic Coverage (Regions/Provinces Served)

Saudi Arabia Home Infusion Therapy Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Chronic Diseases:The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the home infusion therapy market in Saudi Arabia. According to the International Diabetes Federation, the estimated number of adults living with diabetes in Saudi Arabia is approximately 4.3 million. This growing patient population necessitates effective home-based treatment options, leading to an increased demand for home infusion therapies that can provide necessary medications and improve patient outcomes.
  • Rising Demand for Home Healthcare Services:The demand for home healthcare services in Saudi Arabia is projected to grow, driven by an aging population and a preference for at-home care. The Saudi Ministry of Health reported that the number of home healthcare patients increased by 15% from the previous year to the current year, highlighting a shift towards more personalized care. This trend is expected to continue, further propelling the adoption of home infusion therapy as a viable treatment option for patients requiring ongoing medical support.
  • Technological Advancements in Infusion Devices:Innovations in infusion technology are enhancing the efficiency and safety of home infusion therapy. The introduction of smart infusion pumps, which can monitor patient data in real-time, has been a game-changer. In future, the Saudi healthcare sector invested over SAR 1 billion in digital health technologies, indicating a strong commitment to improving patient care through advanced medical devices. This investment is expected to facilitate the growth of home infusion therapy by making it more accessible and user-friendly.

Market Challenges

  • High Cost of Infusion Therapy Equipment:One of the primary challenges facing the home infusion therapy market in Saudi Arabia is the high cost associated with infusion therapy equipment. The average cost of infusion pumps can exceed SAR 10,000, which poses a financial barrier for many patients and healthcare providers. This high initial investment can deter the adoption of home infusion therapy, particularly among lower-income households, limiting market growth potential.
  • Limited Awareness Among Patients and Caregivers:There is a significant gap in awareness regarding home infusion therapy among patients and caregivers in Saudi Arabia. A study revealed that only 30% of patients were aware of home infusion options available to them. This lack of knowledge can lead to underutilization of home healthcare services, hindering the growth of the market. Educational initiatives are essential to bridge this gap and promote the benefits of home infusion therapy.

Saudi Arabia Home Infusion Therapy Market Future Outlook

The future of the home infusion therapy market in Saudi Arabia appears promising, driven by ongoing advancements in technology and a growing emphasis on patient-centric care. As the healthcare system continues to evolve, the integration of telehealth services is expected to enhance patient monitoring and support. Additionally, the increasing investment in healthcare infrastructure will likely facilitate the expansion of home healthcare services, making home infusion therapy more accessible to a broader patient population.

Market Opportunities

  • Expansion of Telehealth Services:The growth of telehealth services presents a significant opportunity for the home infusion therapy market. With the Saudi government investing SAR 500 million in telehealth initiatives in future, patients can receive remote consultations and monitoring, improving adherence to home infusion protocols and enhancing overall care quality.
  • Development of Innovative Infusion Therapies:There is a growing opportunity for the development of innovative infusion therapies tailored to specific patient needs. The Saudi healthcare sector is expected to allocate SAR 1.2 billion towards research and development in future, fostering innovation in drug formulations and delivery methods that can enhance the effectiveness of home infusion therapy.

Scope of the Report

SegmentSub-Segments
By Product Type

Infusion Pumps

Intravenous (IV) Sets

IV Cannulas

Needleless Connectors

Others

By Therapy/Application

Anti-infective Infusion

Parenteral Nutrition

Chemotherapy

Hydration Therapy

Pain Management

Others

By End-User

Homecare Patients

Hospitals

Long-term Care Facilities

Ambulatory Infusion Centers

Others

By Patient Demographics

Pediatric Patients

Adult Patients

Geriatric Patients

Others

By Therapy Duration

Short-term Therapy

Long-term Therapy

Others

By Distribution Channel

Direct Sales

Online Pharmacies

Retail Pharmacies

Home Healthcare Agencies

Hospital Pharmacies

Others

By Geographic Region

Northern and Central Region

Western Region

Eastern Region

Southern Region

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Saudi Food and Drug Authority, Ministry of Health)

Manufacturers and Producers of Infusion Therapy Equipment

Distributors and Retailers of Medical Supplies

Healthcare Providers and Home Healthcare Agencies

Pharmaceutical Companies

Insurance Companies and Payers

Industry Associations and Advocacy Groups

Players Mentioned in the Report:

Baxter International Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Terumo Corporation

Smiths Medical

Medtronic plc

ICU Medical, Inc.

Halyard Health, Inc.

Calea Ltd.

Zyno Medical LLC

Amgen Inc.

Pfizer Inc.

Novartis AG

Roche Holding AG

Sanofi S.A.

Al Faisaliah Medical Systems Co. (FMS)

Gulf Medical Co. Ltd.

Al-Jeel Medical & Trading Co.

Tabuk Pharmaceuticals Manufacturing Co.

Jamjoom Pharma

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Saudi Arabia Home Infusion Therapy Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Saudi Arabia Home Infusion Therapy Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Saudi Arabia Home Infusion Therapy Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of chronic diseases
3.1.2 Rising demand for home healthcare services
3.1.3 Technological advancements in infusion devices
3.1.4 Supportive government initiatives for home healthcare

3.2 Market Challenges

3.2.1 High cost of infusion therapy equipment
3.2.2 Limited awareness among patients and caregivers
3.2.3 Regulatory hurdles in product approvals
3.2.4 Shortage of trained healthcare professionals

3.3 Market Opportunities

3.3.1 Expansion of telehealth services
3.3.2 Increasing investment in healthcare infrastructure
3.3.3 Development of innovative infusion therapies
3.3.4 Growing aging population requiring home care

3.4 Market Trends

3.4.1 Shift towards patient-centric care models
3.4.2 Integration of digital health technologies
3.4.3 Rise in home-based palliative care
3.4.4 Focus on cost-effective healthcare solutions

3.5 Government Regulation

3.5.1 Licensing requirements for home infusion services
3.5.2 Standards for infusion equipment safety
3.5.3 Guidelines for healthcare provider training
3.5.4 Reimbursement policies for home infusion therapy

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Saudi Arabia Home Infusion Therapy Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Saudi Arabia Home Infusion Therapy Market Segmentation

8.1 By Product Type

8.1.1 Infusion Pumps
8.1.2 Intravenous (IV) Sets
8.1.3 IV Cannulas
8.1.4 Needleless Connectors
8.1.5 Others

8.2 By Therapy/Application

8.2.1 Anti-infective Infusion
8.2.2 Parenteral Nutrition
8.2.3 Chemotherapy
8.2.4 Hydration Therapy
8.2.5 Pain Management
8.2.6 Others

8.3 By End-User

8.3.1 Homecare Patients
8.3.2 Hospitals
8.3.3 Long-term Care Facilities
8.3.4 Ambulatory Infusion Centers
8.3.5 Others

8.4 By Patient Demographics

8.4.1 Pediatric Patients
8.4.2 Adult Patients
8.4.3 Geriatric Patients
8.4.4 Others

8.5 By Therapy Duration

8.5.1 Short-term Therapy
8.5.2 Long-term Therapy
8.5.3 Others

8.6 By Distribution Channel

8.6.1 Direct Sales
8.6.2 Online Pharmacies
8.6.3 Retail Pharmacies
8.6.4 Home Healthcare Agencies
8.6.5 Hospital Pharmacies
8.6.6 Others

8.7 By Geographic Region

8.7.1 Northern and Central Region
8.7.2 Western Region
8.7.3 Eastern Region
8.7.4 Southern Region
8.7.5 Others

9. Saudi Arabia Home Infusion Therapy Market Competitive Analysis

9.1 Market Share of Key Players

9.2 KPIs for Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue (Saudi Arabia Home Infusion Therapy, USD Million)
9.2.4 Revenue Growth Rate (YoY %)
9.2.5 Market Share (%)
9.2.6 Number of Patients Served (Saudi Arabia)
9.2.7 Geographic Coverage (Regions/Provinces Served)
9.2.8 Product Portfolio Breadth (No. of Therapy Types/Devices)
9.2.9 Distribution Channel Coverage
9.2.10 Customer Retention Rate (%)
9.2.11 Accreditation/Regulatory Compliance (e.g., SFDA, CBAHI)
9.2.12 Customer Satisfaction Index (Survey Score or NPS)
9.2.13 Average Therapy Cost (SAR per patient)
9.2.14 Local Partnerships/Joint Ventures
9.2.15 Digital Health Integration (e.g., Telehealth, Remote Monitoring)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Baxter International Inc.
9.5.2 B. Braun Melsungen AG
9.5.3 Fresenius Kabi AG
9.5.4 Terumo Corporation
9.5.5 Smiths Medical
9.5.6 Medtronic plc
9.5.7 ICU Medical, Inc.
9.5.8 Halyard Health, Inc.
9.5.9 Calea Ltd.
9.5.10 Zyno Medical LLC
9.5.11 Amgen Inc.
9.5.12 Pfizer Inc.
9.5.13 Novartis AG
9.5.14 Roche Holding AG
9.5.15 Sanofi S.A.
9.5.16 Al Faisaliah Medical Systems Co. (FMS)
9.5.17 Gulf Medical Co. Ltd.
9.5.18 Al-Jeel Medical & Trading Co.
9.5.19 Tabuk Pharmaceuticals Manufacturing Co.
9.5.20 Jamjoom Pharma

10. Saudi Arabia Home Infusion Therapy Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Home Healthcare
10.1.2 Decision-Making Processes
10.1.3 Supplier Selection Criteria
10.1.4 Contracting Practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Home Infusion Facilities
10.2.2 Spending on Training and Development
10.2.3 Budget for Equipment Procurement
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges Faced by Homecare Patients
10.3.2 Issues for Healthcare Providers
10.3.3 Concerns of Long-term Care Facilities
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training Needs
10.4.3 Technology Acceptance
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Expansion Opportunities
10.5.3 User Feedback Mechanisms
10.5.4 Others

11. Saudi Arabia Home Infusion Therapy Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Streams Analysis

1.4 Cost Structure Evaluation

1.5 Key Partnerships Exploration

1.6 Customer Segmentation

1.7 Channels of Distribution


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of healthcare expenditure reports from the Saudi Ministry of Health
  • Review of published studies and white papers on home infusion therapy trends
  • Examination of demographic and epidemiological data relevant to chronic diseases

Primary Research

  • Interviews with healthcare professionals specializing in home healthcare services
  • Surveys with patients currently utilizing home infusion therapy
  • Discussions with pharmacists and infusion therapy providers

Validation & Triangulation

  • Cross-validation of findings through multiple healthcare databases and reports
  • Triangulation of data from patient feedback, healthcare provider insights, and market reports
  • Sanity checks conducted through expert panel reviews and focus groups

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total healthcare spending allocated to home healthcare services
  • Segmentation of market size by therapy type and patient demographics
  • Incorporation of government initiatives promoting home healthcare solutions

Bottom-up Modeling

  • Collection of data on the number of patients receiving home infusion therapy
  • Estimation of average costs associated with home infusion therapy per patient
  • Calculation of market size based on patient volume and service pricing

Forecasting & Scenario Analysis

  • Multi-factor regression analysis considering population growth and aging demographics
  • Scenario modeling based on potential regulatory changes and healthcare policies
  • Development of baseline, optimistic, and pessimistic market projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Home Infusion Therapy Providers60Healthcare Administrators, Infusion Therapy Specialists
Patients Receiving Home Infusion100Chronic Disease Patients, Caregivers
Pharmaceutical Suppliers40Sales Representatives, Product Managers
Healthcare Policy Makers40Health Economists, Regulatory Affairs Managers
Insurance Providers50Claims Analysts, Policy Underwriters

Frequently Asked Questions

What is the current value of the Saudi Arabia Home Infusion Therapy Market?

The Saudi Arabia Home Infusion Therapy Market is valued at approximately USD 401 million, reflecting a significant growth driven by the increasing prevalence of chronic diseases, an aging population, and advancements in home healthcare services.

What factors are driving the growth of home infusion therapy in Saudi Arabia?

Which cities in Saudi Arabia are leading in home infusion therapy services?

What regulations govern home infusion therapy providers in Saudi Arabia?

Other Regional/Country Reports

GCC home infusion therapy market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Indonesia Home Infusion Therapy Market

Malaysia Home Infusion Therapy Market

KSA Home Infusion Therapy Market

APAC Home Infusion Therapy Market

SEA Home Infusion Therapy Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022